Michelle Caruso-Cabrera, Former CNBC Anchor and Chief International Correspondent, Joins Star Mountain Capital as Senior Advisor

NEW YORK--(BUSINESS WIRE)--Apr 29, 2026--

Star Mountain Capital, LLC ("Star Mountain"), a rapidly growing, employee-owned investment firm with ~$5 billion in assets under management ("AUM"), is pleased to announce that Michelle Caruso-Cabrera has joined as Senior Advisor. Ms. Caruso-Cabrera brings 30 years of experience at the nexus of finance, economic development and communication.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429655667/en/

Ms. Caruso-Cabrera has built a distinguished career spanning global financial journalism, economic analysis and corporate leadership bringing value to companies in brand positioning, corporate governance, strategy and international affairs, leveraging her global perspective to navigate complex business and geopolitical environments. She currently serves as Chief Executive of MCC Global Enterprises and is a CNBC Contributor.

"Michelle has demonstrated exceptional ability throughout her career to analyze complex global economic issues and communicate them with clarity and insight," said Brett Hickey, Founder & CEO of Star Mountain Capital. "Her deep understanding of international markets and extensive experience engaging with business and policy leaders will be invaluable as we continue to grow and strengthen our relationships across the marketplace."

“Success in the lower middle-market requires a deep understanding of the unique intricacies of small businesses, combined with a clear view of the global forces shaping their environment,” said Peter K. Scaturro, Star Mountain Capital Vice Chairman. “Michelle’s experience analyzing international markets and communicating complex economic trends strengthens our ability to bring global insights to where they matter most and help companies build resilience across cycles.”

Ms. Caruso-Cabrera was the first Latina anchor at CNBC and the first Chief International Correspondent. She spent more than 20 years covering economic crises and international markets and interviewing presidents, prime ministers and CEOs. She began her career at Univisión Spanish-language news in 1991 and in 1993 received an Emmy for a series she co-produced on the AIDS Crisis.

She serves on the International Advisory Board of the Instituto Empresa in Madrid and is past Board President of Ballet Hispánico in NYC. She is a member of the Council of Foreign Relations, the Economic Club of NY and the Latino Corporate Directors Association. In 2023, she joined the board of Wendy’s and previously served on the board of Del Real Foods, a portfolio company of Palladium Equity.

"Star Mountain has built something truly distinctive: a firm that combines disciplined investment strategies with a strong culture of partnership and employee ownership," said Ms. Caruso-Cabrera. "I am excited to support the firm’s continued growth and to contribute my experience across global markets, economic analysis and corporate leadership."

Ms. Caruso-Cabrera holds a BA in economics from Wellesley College.

About Star Mountain Capital

With ~$5 billion in AUM (committed capital including debt facilities as of 3/31/2026), Star Mountain specializes in providing scalable and data-driven investment solutions across two core strategies:

Star Mountain’s investors include public and private pensions, insurance companies, commercial banks, endowments, foundations, family offices and high-net-worth individuals. Employee-owned and sharing profits with 100% of its U.S. full-time employees, the firm prioritizes alignment of interests to maximize value for stakeholders.

Since 2010, Star Mountain has completed over 100 direct platform investments and 50 secondary/fund investments in the North American lower middle-market. The firm has been recognized as one of the Inc. 5000 fastest-growing private companies and a Best Place to Work by Crain’s New York Business and Pensions & Investments.

For more information, visit www.starmountaincapital.com.

Legal Disclaimer:

This press release does not constitute an offer to sell or a solicitation of an offer to purchase interests in any investment product. Awards and recognitions by third-party rating agencies, companies or publications should not be interpreted as a guarantee of future results or performance. They should not be considered as an endorsement, recommendation or referral of Star Mountain Capital or its representatives by any client or third party. Rankings published by media and industry organizations are based on information provided by the recognized advisor. Additionally, readers should understand that past performance is not indicative of future results. Award descriptions and selection methodologies may vary.

Awards and Recognition Disclosure:

Star Mountain Capital's awards and recognitions are based on third-party evaluations and criteria, which may be subjective. These honors do not imply a guarantee of future performance or an endorsement by current or past clients.

Ranking Methodologies:

Star Mountain Capital is pleased to announce that Michelle Caruso-Cabrera has joined as Senior Advisor.

VIENNA--(BUSINESS WIRE)--Apr 29, 2026--

OrphaCare, a global specialist for the development and marketing of medical devices for drug delivery and part of the AOP Health Group, has appointed Andreas Goppelt as its new Managing Director, succeeding Georg Fischer. In this role, the seasoned medical device expert will focus on broadening the company’s strategic scope and driving its next phase of growth. OrphaCare plays a key role in supporting AOP Health’s integrated therapies approach, and the Group’s long-term expansion.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260429303533/en/

Andreas Goppelt brings more than 25 years of leadership experience across MedTech, biotechnology and the pharmaceutical industry. He has a proven track record of driving innovation, scaling global organizations, and delivering growth in highly regulated healthcare environments.

In his new role, Goppelt will drive OrphaCare’s expansion through a combination of geographic growth and portfolio expansion by advancing a cutting-edge product pipeline with targeted mergers and acquisitions.

Goppelt will prioritize organizational agility, digital transformation, and operational excellence. In parallel he will foster a high-performance culture built on accountability, collaboration, and empowerment.

Improving Patient Care

“With this appointment, we are further strengthening OrphaCare’s development and its contribution to improving patient care in complex and underserved therapeutic areas,” said Martin Steinhart, CEO of AOP Health Group. “OrphaCare is an essential part of our integrated therapies´ approach. Andreas Goppelt brings the experience and strategic perspective needed to further expand this important part of our business.”

“Working at OrphaCare means taking responsibility for patients who often have limited treatment options,” said Goppelt. “This requires not only expertise, but also clarity in how we work together and a shared commitment to making a real difference. My goal is to create an environment where people take ownership and are proud of the impact they have.”

About Andreas Goppelt

Prior to joining OrphaCare, Andreas Goppelt held senior executive roles including Chief Technology Officer and Chief Executive Officer. Most recently, he served at Ottobock, where he led global R&D transformation initiatives and oversaw large-scale international operations. Earlier in his career, he co-founded SWITCH Biotech and held leadership roles at Baxter BioSurgery.

Andreas Goppelt holds a Ph.D. in Biochemistry from the Ludwig-Maximilians-Universität München.

About AOP Health

AOP Health is a global enterprise group with roots in Austria, where the headquarters of AOP Orphan Pharmaceuticals GmbH ("AOP Health") is located. Since 1996, the AOP Health Group has been dedicated to developing innovative solutions to address unmet medical needs, particularly in the fields of rare diseases and intensive care medicine. The group has established itself internationally as a pioneer in integrated therapy solutions and operates worldwide through subsidiaries, representations, and a strong network of partners. With the claim "Needs. Science. Trust." the AOP Health Group emphasizes its commitment to research and development, as well as the importance of building relationships with physicians and patient advocacy groups to ensure that the needs of these stakeholders are reflected in all aspects of the company’s actions. (aop-health.com)

About OrphaCare

As part of the AOP Health Group, OrphaCare is dedicated to advancing therapies for rare diseases by developinginnovative, tailored solutions for patients with complex medical needs. Since 2018, the company has focused on organizing patient care, bringing advanced medical devices to market, and consistently placing patients at the center of everything it does.

Portrait Andreas Goppelt, Managing Director OrphaCare (copyright: AOP Health/Studio Koekart)